Greece's government claims €2.5 billion will be collected from a measure to seize cash from local governments. But is that true? And will it be enough?
Cramer has been a big believer in Opko Health, which has been on a run since Pfizer put down nearly $300 million for one of its drugs. More upside possible?
Greece looks set to get kicked out of the Eurozone in a matter of days or weeks. Here's why, and here's what you can do to prepare.
The Nikkei has been chugging higher ever since Abenomics began, but direct BOJ asset purchases in the Japanese stock market may be soon coming to an end.
Vanda's Hetlioz is not the prettiest approval story, but over 350 prescriptions since February for a $60,000 orphan drug is not horrible. It'll need 1,500 prescriptions to break even.
Raptor released positive phase 3 data for its Huntington's treatment in February, but since then little has happened. The share price is now depressed, presenting a good entry point.
Before anything, there is the money supply. Stocks can rise only if the money supply is increasing. Right now it isn't.
When a country defaults, it usually repegs to the U.S. dollar in order to re-establish a basic economy. But if the U.S. itself defaults, it can't peg to the dollar.
The monetary base just crossed the $4 trillion mark for the first time ever. Price inflation is heating up and becoming more obvious.
Musk's move to open Tesla's patent portfolio appears to have been a politically savvy move to pressure politicians into letting him sell directly to consumers.